Author/Authors :
Fausto Biancari، نويسنده , , Jarmo Lahtinen، نويسنده , , Risto Ojala، نويسنده , , Lauri Ahvenj?rvi، نويسنده , , Airi Jartti، نويسنده , , Martti Mosorin، نويسنده , , Jouni Heikkinen، نويسنده , , Panu Taskinen، نويسنده , , Martti Lepoj?rvi، نويسنده ,
Abstract :
Purpose
The Spyder aortic connector (Medtronic, Minneapolis, MN) is a new, promising connector device and its safety and efficacy have been evaluated in this study.
Description
Twenty-two patients were randomized to proximal vein graft anastomosis with the Spyder aortic connector (Medtronic) or hand-sewn technique.
Evaluation
Twenty patients underwent multi-detector computed tomographic scans of the chest 6 months after surgery to evaluate vein graft patency. We have failed to successfully deploy three Spyder connector devices. Thus in this study we have evaluated the graft patency of 19 hand-sewn grafts and of 19 vein grafts anastomosed with the Spyder anastomotic device. Three vein grafts whose proximal anastomosis was accomplished with the Spyder anastomotic connector were occluded and all hand-sewn vein grafts were patent (16% vs 0%; p = 0.23). Stenosis of the proximal anastomosis was observed in seven vein grafts (37%), accomplished with the Spyder anastomotic connector, and in one (5%) hand-sewn vein graft (p = 0.042).
Conclusions
The results of this study suggest that the use of the Spyder aortic connector device is associated with suboptimal 6-month graft patency.